News Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1259 (Published 19 May 2022) Cite this as: BMJ 2022;377:o1259 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Marburg virus: First cases in Rwanda spark international alarm BMJ October 02, 2024, 387 q2155; DOI: https://doi.org/10.1136/bmj.q2155 Mpox is accelerating antimicrobial resistance in Africa, officials warn BMJ September 27, 2024, 386 q2124; DOI: https://doi.org/10.1136/bmj.q2124 Politicians are failing to prepare for next pandemic, warns head of European health agency BMJ September 26, 2024, 386 q2115; DOI: https://doi.org/10.1136/bmj.q2115 Whooping cough: Fivefold rise in US cases spells return to pre-pandemic levels BMJ September 26, 2024, 386 q2114; DOI: https://doi.org/10.1136/bmj.q2114 Boy who survived life support withdrawal confirms “medicine is a science of uncertainty,” says judge BMJ September 26, 2024, 386 q2108; DOI: https://doi.org/10.1136/bmj.q2108
